T1	Participants 48 77	patients with type 2 diabetes
T2	Participants 211 240	Patients with type 2 diabetes
T3	Participants 580 609	patients with type 2 diabetes
T4	Participants 672 749	5238 patients with type 2 diabetes who had evidence of macrovascular disease.
T5	Participants 1556 1569	2605 patients
T6	Participants 2424 2439	type 2 diabetes